HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.590
+0.050 (1.41%)
At close: Aug 8, 2025, 4:00 PM
3.660
+0.070 (1.95%)
After-hours: Aug 8, 2025, 5:07 PM EDT
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$290
Profits / Employee
-$584,349
Market Cap
8.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 15 | 0 | - |
Apr 30, 2024 | 15 | 3 | 25.00% |
Apr 30, 2023 | 12 | 0 | - |
Apr 30, 2022 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HSCS News
- 15 days ago - HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - GlobeNewsWire
- 2 months ago - Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - GlobeNewsWire
- 2 months ago - HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewsWire
- 2 months ago - HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - GlobeNewsWire
- 3 months ago - HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson - GlobeNewsWire
- 3 months ago - HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - GlobeNewsWire
- 3 months ago - HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - GlobeNewsWire